Document Detail


Colchicine reduces postoperative atrial fibrillation: results of the Colchicine for the Prevention of the Postpericardiotomy Syndrome (COPPS) atrial fibrillation substudy.
MedLine Citation:
PMID:  22090167     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: Inflammation and pericarditis may be contributing factors for postoperative atrial fibrillation (POAF), and both are potentially affected by antiinflammatory drugs and colchicine, which has been shown to be safe and efficacious for the prevention of pericarditis and the postpericardiotomy syndrome (PPS). The aim of the Colchicine for the Prevention of the Post-Pericardiotomy Syndrome (COPPS) POAF substudy was to test the efficacy and safety of colchicine for the prevention of POAF after cardiac surgery.
METHODS AND RESULTS: The COPPS POAF substudy included 336 patients (mean age, 65.7±12.3 years; 69% male) of the COPPS trial, a multicenter, double-blind, randomized trial. Substudy patients were in sinus rhythm before starting the intervention (placebo/colchicine 1.0 mg twice daily starting on postoperative day 3 followed by a maintenance dose of 0.5 mg twice daily for 1 month in patients ≥70 kg, halved doses for patients <70 kg or intolerant to the highest dose). The substudy primary end point was the incidence of POAF on intervention at 1 month. Despite well-balanced baseline characteristics, patients on colchicine had a reduced incidence of POAF (12.0% versus 22.0%, respectively; P=0.021; relative risk reduction, 45%; number needed to treat, 11) with a shorter in-hospital stay (9.4±3.7 versus 10.3±4.3 days; P=0.040) and rehabilitation stay (12.1±6.1 versus 13.9±6.5 days; P=0.009). Side effects were similar in the study groups.
CONCLUSION: Colchicine seems safe and efficacious in the reduction of POAF with the potentiality of halving the complication and reducing the hospital stay.
Authors:
Massimo Imazio; Antonio Brucato; Paolo Ferrazzi; Maria Elena Rovere; Anna Gandino; Roberto Cemin; Stefania Ferrua; Riccardo Belli; Silvia Maestroni; Caterina Simon; Edoardo Zingarelli; Alberto Barosi; Fabrizio Sansone; Davide Patrini; Ettore Vitali; Rita Trinchero; David H Spodick; Yehuda Adler;
Related Documents :
22167757 - Comparison of neurocognitive functions after beating-heart mitral valve replacement wit...
21613787 - Cilostazol in acute ischemic stroke treatment (caist trial): a randomized double-blind ...
25173897 - Dual application versus single application of povidone-iodine in reducing surgical site...
25269897 - Circumferential decompression via the posterior approach for the surgical treatment of ...
21126887 - Danish study of a modified atkins diet for medically intractable epilepsy in children: ...
23808507 - Is comorbid status the best predictor of one-year mortality in patients with severe sep...
Publication Detail:
Type:  Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't     Date:  2011-11-16
Journal Detail:
Title:  Circulation     Volume:  124     ISSN:  1524-4539     ISO Abbreviation:  Circulation     Publication Date:  2011 Nov 
Date Detail:
Created Date:  2011-11-22     Completed Date:  2012-01-12     Revised Date:  2012-03-01    
Medline Journal Info:
Nlm Unique ID:  0147763     Medline TA:  Circulation     Country:  United States    
Other Details:
Languages:  eng     Pagination:  2290-5     Citation Subset:  AIM; IM    
Affiliation:
Cardiology Department, Maria Vittoria Hospital, Via Cibrario 72, Turin, Italy. massimo_imazio@yahoo.it
Data Bank Information
Bank Name/Acc. No.:
ClinicalTrials.gov/NCT00128427
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Anti-Arrhythmia Agents / adverse effects,  therapeutic use*
Atrial Fibrillation / epidemiology*,  physiopathology,  prevention & control*
Cardiac Surgical Procedures*
Colchicine / adverse effects,  therapeutic use*
Dose-Response Relationship, Drug
Double-Blind Method
Female
Humans
Incidence
Kaplan-Meier Estimate
Length of Stay
Male
Middle Aged
Postoperative Period
Prospective Studies
Treatment Outcome
Chemical
Reg. No./Substance:
0/Anti-Arrhythmia Agents; 64-86-8/Colchicine
Investigator
Investigator/Affiliation:
M Imazio / ; A Chinaglia / ; B Demichelis / ; S Ierna / ; S Maestroni / ; C Simon / ; D Cumetti / ; P Ferrazzi / ; M E Rovere / ; E Zingarelli / ; F Sansone / ; A Gandino / ; A Barosi / ; D Patrini / ; E Vitali / ; R Cemin / ; S Ferrua / ; M R Conte /
Comments/Corrections
Comment In:
Nat Rev Cardiol. 2012 Feb;9(2):67   [PMID:  22143081 ]
Nat Rev Cardiol. 2012 Feb;9(2):67   [PMID:  22143082 ]
Circulation. 2011 Nov 22;124(21):2281-2   [PMID:  22105193 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Brugada-like syndrome in infancy presenting with rapid ventricular tachycardia and intraventricular ...
Next Document:  Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral ar...